Mei C, Xu G, Zheng C, Xie Y, Li M, Shao Y, Yao R, Tao S, Jiang W, Guo J, Zheng Z, Wang W, Zhou X, Ma L, Ye L, Luo Y, Yang C, Yu W, Xie W, Jin J, Tong H. Recombinant human erythropoietin plus all-<i>trans</i> retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial. haematol [Internet]. 2026Feb.1 [cited 2026Feb.8];111(2):646-55. Available from: https://haematologica.org/article/view/12102